AI-generated summary
This retrospective study of 12 patients with intractable recurrent chalazion, all refractory to surgery and antibiotics, examined outcomes of combined doxycycline and intense pulsed light therapy. The authors report that 83.3% of patients were classified as successes, with significant improvements in meibomian gland scores, though the small, uncontrolled design limits how strongly these results can be interpreted.
- Participants
- 12
- Who or what was studied
- Patients with intractable recurrent chalazion refractory to surgical intervention and antibiotics; 5 male and 7 female, average age 36.3 years
- Limits stated in the abstract
- Retrospective design with a small sample of 12 patients and no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Management of chalazion, characterized by noninfectious chronic granulomatous inflammation of the meibomian glands (MGs), remains challenging in ophthalmic practice, particularly because of its propensity for recurrence even after surgical intervention. This study aimed to evaluate the combined efficacy of doxycycline and intense pulsed light (IPL) therapy for treating intractable recurrent chalazion, focusing on reducing recurrence rates and improving MG status. This retrospective study included patients with intractable recurrent chalazion refractory to conventional treatments including surgical intervention and antibiotics. All patients were treated with a combination of doxycycline and IPL therapy. Clinical assessments included best-corrected visual activity, intraocular pressure, and MG evaluations using slit-lamp biomicroscopy and Keratograph 5 M topography. The study included 12 patients (5 male and 7 female) with an average age of 36.3 years. Treatment outcomes were categorized as 'success' (83.3%), 'stationary' (8.3%), and 'failure' (8.3%). Significant improvements were noted in the MG expression scores (p = 0.038), MG quality scores (p = 0.045), and lid margin telangiectasia scores (p = 0.002). In addition, significant improvement in meiboscores was observed (p = 0.002). The combination of doxycycline and IPL therapy demonstrated promising efficacy in treating intractable recurrent chalazion, with significant improvements in MG function and reduced recurrence rates. This treatment approach offers a viable alternative for patients with recurrent chalazions, particularly for those who are unresponsive to conventional treatments.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.